Terazosin Hydrochloride
Product Images NDC 54868-4247

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Terazosin Hydrochloride (NDC 54868-4247). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Terazosin Hydrochloride 2 mg Label (4247)

Packaging label for Terazosin Hydrochloride Capsules, 2 mg, by Physicians Total Care, Inc. The label indicates the package contains 30 capsules and includes warnings, lot number, expiration date, and storage instructions. The label features the Physicians Total Care logo and states the NDC 54868-4274-0.*

FDA Label Image

Terazosin Hydrochloride 5 mg Label (4248)

Label for Terazosin Hydrochloride (Terazosin HCL) capsules, 5 mg strength, containing 30 capsules. The product is labeled by Physicians Total Care, Inc. The label includes dosing and storage instructions, a caution about federal law on dispensing, and a lot number and expiration date.*

FDA Label Image

Terazosin Hydrochloride 10 mg Label (4249)

Terazosin Hydrochloride 10 mg capsules packaging label from Physicians Total Care, Inc. The label indicates a package containing 30 capsules. It includes cautionary text stating federal law prohibits dispensing without a prescription, storage conditions, lot number, expiration date, and barcode information.*

FDA Label Image

Terazosin Hydrochloride 1 mg Label (4803)

Terazosin Hydrochloride (Terazosin HCL Capsules) 1 mg, labeler Physicians Total Care, Inc. White capsule bottle label indicates a quantity of 30 capsules. Instructions state to refer to the accompanying insert for use and dosage information. Contains caution regarding federal law and dispensing without prescription. Features lot number, expiration date, barcode, and storage instructions.*

FDA Label Image

Terazosin Hydrochloride Chemical Structure (6059f605 5039 4a4c Aebd 43cc5ee80a43 01)

Chemical structure of Terazosin Hydrochloride showing the molecular arrangement of atoms including aromatic rings, amino group, and hydrochloride component.*

FDA Label Image

Figure 1 (6059f605 5039 4a4c Aebd 43cc5ee80a43 02)

The image contains two line graphs comparing the effects of Terazosin and placebo. The left graph shows mean change in total symptom score from baseline over 3 months for 54 Terazosin and 55 placebo patients. The right graph depicts mean increase in peak flow rate (mL/sec) over baseline during the same period for 52 Terazosin and 54 placebo patients.*

FDA Label Image

Figure 2 (6059f605 5039 4a4c Aebd 43cc5ee80a43 03)

A line graph showing the mean change from baseline over a 30-month period. The x-axis represents time in months, and the y-axis represents mean change from baseline with values ranging from 0 to -7. Data points decrease rapidly initially and then gradually stabilize, with several points marked with an asterisk indicating statistical significance.*

FDA Label Image

Figure 3 (6059f605 5039 4a4c Aebd 43cc5ee80a43 04)

A line graph showing the mean change from baseline in mL/sec over a 30-month period. The x-axis represents time in months from 0 to 30, and the y-axis shows the mean change from baseline ranging from 0.0 to 4.5 mL/sec. Data points increase over time, with several marked by asterisks indicating statistical significance.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.